Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension. (Q47609049)

4 February 2018

title

Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension. (English)

1 reference

4 February 2018

0 references

1 reference

5

Mihkel Zilmer

1 reference

4 February 2018

7

Tiiu Kullisaar

1 reference

4 February 2018

6

Kersti Zilmer

1 reference

4 February 2018

3

Jaak Kals

1 reference

4 February 2018

4

Maksim Zagura

1 reference

4 February 2018

1

Martin Serg

1 reference

4 February 2018

2

Priit Kampus

1 reference

4 February 2018

8

Jaan Eha

1 reference

4 February 2018

18 June 2012

1 reference

4 February 2018

Scandinavian Journal of Clinical and Laboratory Investigation

published in

1 reference

4 February 2018

volume

72

1 reference

4 February 2018

page(s)

427-432

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

The relationship between inflammation and arterial stiffness in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Isoprostanes: potential markers of oxidant stress in atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Measurement of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Nebivolol increases arterial distensibility in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Guidance on the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Measures of oxidized low-density lipoprotein and oxidative stress are not related and not elevated in otherwise healthy men with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Candesartan effect on inflammation in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Thiazide diuretics, endothelial function, and vascular oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365513.2012.691991

10.3109/00365513.2012.691991

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6wdiletbkjaclogl4hbrws2j6i

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_6wdiletbkjaclogl4hbrws2j6i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6wdiletbkjaclogl4hbrws2j6i

mapped directly with Wikidata item

30 July 2022

based on heuristic

1 reference

https://api.fatcat.wiki/v0/release/6wdiletbkjaclogl4hbrws2j6i